| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |